
    
      To identify genetic and biomarker factors which affect the expression of Parkinson's Disease.

      Primary objective: To define the severity and rates of progression of clinical features of
      Parkinson's Disease.

      Secondary objective: To relate clinical phenomenology of Parkinson's disease to genetic and
      biomarker changes.
    
  